{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:06:46Z","timestamp":1783030006524,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001332","name":"CSIR","doi-asserted-by":"crossref","award":["BSC00114"],"award-info":[{"award-number":["BSC00114"]}],"id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ejmech.2015.09.004","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T06:05:09Z","timestamp":1441692309000},"page":"418-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Designing, synthesis of selective and high-affinity chalcone-benzothiazole hybrids as Brugia malayi thymidylate kinase inhibitors: In\u00a0vitro validation and docking studies"],"prefix":"10.1016","volume":"103","author":[{"given":"Koneni V.","family":"Sashidhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa Rao","family":"Avula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan Kumar","family":"Doharey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Ravithej","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal M.","family":"Balaramnavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailja","family":"Misra-Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Rathaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra Kumar","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.09.004_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1196\/annals.1425.036","article-title":"Eliminating lymphatic filariasis \u2013 a view from the field","volume":"1136","author":"Streit","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2015.09.004_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0020-7519(02)00062-0","article-title":"Lymphatic filariasis: new insights into an old disease","volume":"32","author":"Melrose","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2015.09.004_bib3","series-title":"WHO Global Programme to Eliminate Lymphatic Filariasis Progress Report for 2000\u20132009 and Strategic Plan 2010\u20132020","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.ejmech.2015.09.004_bib4","series-title":"Informal Consultation on Evaluation of Morbidity in Lymphatic Filariasis","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.ejmech.2015.09.004_bib5","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(07)60942-8","article-title":"Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study","volume":"369","author":"Osei-Atweneboana","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2015.09.004_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S0031182007002363","article-title":"An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy","volume":"134","author":"Schwab","year":"2007","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2015.09.004_bib7","series-title":"WHO\/OCP\/OCT\/83.1","author":"Ginger","year":"1983"},{"key":"10.1016\/j.ejmech.2015.09.004_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.parint.2008.03.004","article-title":"Molecular cloning and characterization of Brugia malayi hexokinase","volume":"57","author":"Singh","year":"2008","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2015.09.004_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00436-003-1014-3","article-title":"4-Methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one: a novel DNA topoisomerase II inhibitor with adulticidal and embryostatic activity against sub-periodic Brugia malayi","volume":"92","author":"Misra-Bhattacharya","year":"2004","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2015.09.004_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bmcl.2004.10.046","article-title":"Syntheses of 2,4,6-trisubstituted pyrimidine derivatives as a new class of antifilarial topoisomerase II inhibitors","volume":"15","author":"Katiyar","year":"2005","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.09.004_bib11","series-title":"Nematodes: Morphology, Functions and Management Strategies","article-title":"Filariasis: biochemistry and chemotherapeutic targets","author":"Saxena","year":"2013"},{"key":"10.1016\/j.ejmech.2015.09.004_bib12a","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.actatropica.2014.02.003","article-title":"Molecular cloning and characterization of Brugia malayi thymidylate kinase","volume":"133","author":"Doharey","year":"2014","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2015.09.004_bib12b","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0969-2126(00)00149-0","article-title":"Insights into the phosphoryl transfer mechanism of human thymidylate kinase gained from crystal structures of enzyme complexes along the reaction coordinate","volume":"8","author":"Ostermann","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2015.09.004_bib12c","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/0929867053363432","article-title":"Novel chemical strategies for thymidylate synthase inhibition","volume":"12","author":"Gmeiner","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib12d","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejmech.2014.09.099","article-title":"Design of inhibitors of thymidylate kinase from Variola virus as new selective drugs against smallpox","volume":"91","author":"Guimaraes","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib12e","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1080\/07391102.2013.830578","article-title":"Preventing the return of smallpox: molecular modeling studies on thymidylate kinase from Variola virus","volume":"32","author":"Guimaraes","year":"2014","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2015.09.004_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.phrs.2005.12.008","article-title":"Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats","volume":"53","author":"Zhan","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2015.09.004_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2174\/0929867053363153","article-title":"Chalcones: an update on cytotoxic and chemoprotective properties","volume":"12","author":"Go","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib15","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.bmc.2004.03.071","article-title":"Antibacterial chalcones-bioisosteric replacement of the 4\u2032-hydroxy group","volume":"12","author":"Nielsen","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib16","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1021\/jm0101747","article-title":"Antimalarial alkoxylated and hydroxylated chalcones [corrected]: structure-activity relationship analysis","volume":"44","author":"Liu","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib17","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1016\/j.bmc.2008.06.031","article-title":"Synthesis and cytotoxic, anti-inflammatory, and anti-oxidant activities of 2\u2032,5'-dialkoxylchalcones as cancer chemopreventive agents","volume":"16","author":"Cheng","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4269\/ajtmh.2009.80.764","article-title":"Antifilarial activity of 1,3-diarylpropen-1-one: effect on glutathione-S-transferase, a phase II detoxification enzyme","volume":"80","author":"Awasthi","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2015.09.004_bib19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib20a","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejmech.2014.05.029","article-title":"Synthesis and antifilarial activity of chalcone-thiazole derivatives against a human lymphatic filarial parasite, Brugia malayi","volume":"81","author":"Sashidhara","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib20b","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.bmcl.2012.01.009","article-title":"In\u00a0vitro and in\u00a0vivo antifilarial activity evaluation of 3,6-epoxy [1,5]dioxocines: a new class of antifilarial agents","volume":"22","author":"Sashidhara","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.09.004_bib20c","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.tetlet.2012.07.001","article-title":"A\u00a0facile and efficient Bi(III) catalyzed synthesis of 1,1-dihydroperoxides and 1,2,4,5-tetraoxanes","volume":"53","author":"Sashidhara","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2015.09.004_bib20d","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1039\/C5GC00756A","article-title":"Molecular iodine catalysed one-pot synthesis of chromeno[4,3-b]quinolin-6-ones under microwave irradiation","author":"Sashidhara","year":"2015","journal-title":"Green Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib20e","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.bmc.2012.03.011","article-title":"Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores","volume":"20","author":"Sashidhara","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib20f","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejmech.2014.10.068","article-title":"Identification of quinoline-chalcone hybrids as potential antiulcer agents","volume":"89","author":"Sashidhara","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib21","first-page":"10","article-title":"Antifilarial activity of CGP 20376 against subperiodic Brugia malayi in the leaf-monkey Presbytis cristata","volume":"41","author":"Mak","year":"1990","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.ejmech.2015.09.004_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/BJ20091880","article-title":"Structural basis for the efficient phosphorylation of AZT-MP (3\u2032-azido-3\u2032-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase","volume":"428","author":"Whittingham","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2015.09.004_bib23","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.09.004_bib24a","series-title":"Enzyme Kinetics","author":"Segel","year":"1993"},{"key":"10.1016\/j.ejmech.2015.09.004_bib24b","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejmech.2015.01.035","article-title":"Synthesis, molecular docking and Brugia malayi thymidylate kinase (BmTMK) enzyme inhibition study of novel derivatives of [6]-shogaol","volume":"93","author":"Singh","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib25","first-page":"21","article-title":"Studies on the causation of adverse reactions in microfilaraemic host following diethylcarbamazine therapy (Dipetalonema viteae in Mastomys natalensis)","volume":"36","author":"Singh","year":"1985","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.ejmech.2015.09.004_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0001-706X(98)00016-3","article-title":"Development of in\u00a0vitro screening system for assessment of antifilarial activity of compounds","volume":"70","author":"Mukherjee","year":"1998","journal-title":"Acta trop."},{"key":"10.1016\/j.ejmech.2015.09.004_bib27","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00436-011-2380-x","article-title":"Gedunin and photogedunin of Xylocarpus granatum possess antifilarial activity against human lymphatic filarial parasite Brugia malayi in experimental rodent host","volume":"109","author":"Misra","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2015.09.004_bib28","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.004_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/1074-5521(95)90050-0","article-title":"Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming","volume":"2","author":"Gehlhaar","year":"1995","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2015.09.004_bib30","series-title":"Proceedings of the Seventh International Conference on Evolutionary Programming","first-page":"449","article-title":"Fully automated and rapid flexible docking of inhibitors covalently bound to serine proteases in evolutionary programming VII.","author":"Gehlhaar","year":"1998"},{"key":"10.1016\/j.ejmech.2015.09.004_bib31","series-title":"Catalyst, Release Version 4.1","year":"2006"},{"key":"10.1016\/j.ejmech.2015.09.004_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2013.09.032","article-title":"Drug\/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets","volume":"721","author":"Saxena","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.09.004_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/1062936X.2014.909197","article-title":"Modelling the binding affinity of steroids to zebrafish sex hormone-binding globulin","volume":"25","author":"Saxena","year":"2014","journal-title":"Sar. QSAR Environ. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415302488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415302488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T03:54:54Z","timestamp":1567137294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415302488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":43,"alternative-id":["S0223523415302488"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.09.004","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing, synthesis of selective and high-affinity chalcone-benzothiazole hybrids as Brugia malayi thymidylate kinase inhibitors: In\u00a0vitro validation and docking studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}